These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23166018)

  • 1. Generating extracellular amyloid aggregates using E. coli cells.
    Sivanathan V; Hochschild A
    Genes Dev; 2012 Dec; 26(23):2659-67. PubMed ID: 23166018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of a yeast prion protein to an infectious form in bacteria.
    Garrity SJ; Sivanathan V; Dong J; Lindquist S; Hochschild A
    Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10596-601. PubMed ID: 20484678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Prion Domain Sequences Ensure Efficient Amyloid Propagation by Promoting Chaperone Binding or Processing In Vivo.
    Langlois CR; Pei F; Sindi SS; Serio TR
    PLoS Genet; 2016 Nov; 12(11):e1006417. PubMed ID: 27814358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP modulates self-perpetuating conformational conversion generating structurally distinct yeast prion amyloids that limit autocatalytic amplification.
    Mahapatra S; Sarbahi A; Punia N; Joshi A; Avni A; Walimbe A; Mukhopadhyay S
    J Biol Chem; 2023 May; 299(5):104654. PubMed ID: 36990219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bacterial export system for generating extracellular amyloid aggregates.
    Sivanathan V; Hochschild A
    Nat Protoc; 2013; 8(7):1381-90. PubMed ID: 23787895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast prions form infectious amyloid inclusion bodies in bacteria.
    Espargaró A; Villar-Piqué A; Sabaté R; Ventura S
    Microb Cell Fact; 2012 Jun; 11():89. PubMed ID: 22731490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Amyloid Polymorphism on Prion-Chaperone Interactions in Yeast.
    Killian AN; Miller SC; Hines JK
    Viruses; 2019 Apr; 11(4):. PubMed ID: 30995727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro.
    Derkatch IL; Uptain SM; Outeiro TF; Krishnan R; Lindquist SL; Liebman SW
    Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12934-9. PubMed ID: 15326312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Do Yeast Cells Contend with Prions?
    Wickner RB; Edskes HK; Son M; Wu S; Niznikiewicz M
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physical dimensions of amyloid aggregates control their infective potential as prion particles.
    Marchante R; Beal DM; Koloteva-Levine N; Purton TJ; Tuite MF; Xue WF
    Elife; 2017 Sep; 6():. PubMed ID: 28880146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modification of [PSI+] prion properties by the combination of amino acid changes within Sup35 protein N-domain].
    Bondarev SA; Shirokolobova ED; Trubitsyna NP; Zhuravleva GA
    Mol Biol (Mosk); 2014; 48(2):314-21. PubMed ID: 25850301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequestration of Sup35 by aggregates of huntingtin fragments causes toxicity of [PSI+] yeast.
    Zhao X; Park YN; Todor H; Moomau C; Masison D; Eisenberg E; Greene LE
    J Biol Chem; 2012 Jul; 287(28):23346-55. PubMed ID: 22573320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleation seed size determines amyloid clearance and establishes a barrier to prion appearance in yeast.
    Villali J; Dark J; Brechtel TM; Pei F; Sindi SS; Serio TR
    Nat Struct Mol Biol; 2020 Jun; 27(6):540-549. PubMed ID: 32367069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylphosphatidylinositol anchoring directs the assembly of Sup35NM protein into non-fibrillar, membrane-bound aggregates.
    Marshall KE; Offerdahl DK; Speare JO; Dorward DW; Hasenkrug A; Carmody AB; Baron GS
    J Biol Chem; 2014 May; 289(18):12245-63. PubMed ID: 24627481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid fibrils embodying distinctive yeast prion phenotypes exhibit diverse morphologies.
    Ghosh R; Dong J; Wall J; Frederick KK
    FEMS Yeast Res; 2018 Sep; 18(6):. PubMed ID: 29846554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian amyloidogenic proteins promote prion nucleation in yeast.
    Chandramowlishwaran P; Sun M; Casey KL; Romanyuk AV; Grizel AV; Sopova JV; Rubel AA; Nussbaum-Krammer C; Vorberg IM; Chernoff YO
    J Biol Chem; 2018 Mar; 293(9):3436-3450. PubMed ID: 29330303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human J-protein DnaJB6b Cures a Subset of Saccharomyces cerevisiae Prions and Selectively Blocks Assembly of Structurally Related Amyloids.
    Reidy M; Sharma R; Roberts BL; Masison DC
    J Biol Chem; 2016 Feb; 291(8):4035-47. PubMed ID: 26702057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells.
    Speare JO; Offerdahl DK; Hasenkrug A; Carmody AB; Baron GS
    EMBO J; 2010 Feb; 29(4):782-94. PubMed ID: 20057357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth phase-dependent changes in the size and infectivity of SDS-resistant Sup35p assemblies associated with the [PSI
    Wang K; Melki R; Kabani M
    Mol Microbiol; 2019 Sep; 112(3):932-943. PubMed ID: 31206803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for transmission barrier and interference between closely related prion proteins in yeast.
    Afanasieva EG; Kushnirov VV; Tuite MF; Ter-Avanesyan MD
    J Biol Chem; 2011 May; 286(18):15773-80. PubMed ID: 21454674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.